Monday, September 07, 8:00 AM - 11:59 PM

ILCA 2020 Welcome Address
    The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
    Speaker(s)
    Speaker
    Bruno Sangro
    Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)

      Monday, September 07, 9:00 AM - 11:59 PM

      Basic Science Symposium: Molecular pathogenesis and targets in cholangiocarcinoma
        Speaker(s)
        Speaker
        Daniela Sia
        Assistant Professor in the Division of Liver Diseases, Department of Medicine, at Icahn School of Medicine at Mount Sinai (ISMMS)
        Speaker
        Gregory Gores
        Executive Dean for Research, Physician Scientist
        Mayo Clinic
        Speaker
        Jesper B. Andersen
        Associate Professor and Group leader
        University of Copenhagen · Biotech Research and Innovation Centre (BRIC)
        • On-Demand Session
        ILCA guidance symposium: Systemic Therapy Guidance and Biomarker Development in HCC
          Speaker(s)
          Speaker
          Amit Singal
          Associate Professor at UT Southwestern Medical Center
          Speaker
          Augusto Villanueva
          Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
          Speaker
          R.Kate Kelley
          Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).
          Speaker
          Tim Meyer
          Professor of Experimental Cancer Medicine at UCL and Honorary Consultant in Medical Oncology at the Royal Free and ULCH Hospitals. ILCA Communication Committee Chair.
          • On-Demand Session
          Sequencing and Stratification of Systemic Therapy in HCC Symposium
            Speaker(s)
            Session Chair
            Lorenza Rimassa
            Deputy Director Medical Oncology Unit Humanitas Cancer Center Humanitas Research Hospital - IRCCS, Milan, Italy
            Session Chair
            R.Kate Kelley
            Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).
            Speaker
            Ann-Lii Cheng
            Director, NTU Cancer Center
            National Taiwan University Cancer Center
            Speaker
            Anthony El-Khoueiry
            Associate Professor of Clinical Medicine;Norris Cancer Center CISO
            Speaker
            Bruno Sangro
            Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)
            Speaker
            David J. Pinato
            Clinical Senior Lecturer in Medical Oncology
            Imperial College London
            Speaker
            Gregory Gores
            Executive Dean for Research, Physician Scientist
            Mayo Clinic
            Speaker
            Josep Llovet
            Prof.
            IDIBAPS-HOSPITAL CLÍNIC / ICAHN SCHOOL OF MEDICINE
            Speaker
            Laura Kulik
            Hepatology & Liver Transplantation Professor, Medicine, Northwestern University Medical School, Chicago
            Speaker
            Maria Reig
            Hepatic Oncology (BCLC)
            Hospital Clinic - Barcelona
            Speaker
            Richard Finn
            Professor of Clinical Medicine Division of Hematology/ Oncology UCLA David Geffen School of Medicine University of California, Los Angeles
            Speaker
            Stephen Chan
            Associate Professor
            Department of Clinical Oncology, The Chinese University of Hong Kong
            • On-Demand Session
            STW: Molecular diversity and systemic treatment for HCC and Surgery in the management of HCC: role of surgeons and the radiologists
              Speaker(s)
              Speaker
              Amaia Lujambio
              Ph.D. Assistant Professor
              Icahn School of Medicine at Mount Sinai
              Speaker
              Andrew Zhu
              Director of Jiahui International Cancer Center, Director Emeritus of Liver Cancer Research at Massachusetts General Hospital Cancer Center, and Professor of Medicine at Harvard Medical School
              Speaker
              Eric Vibert
              Academic surgeon at AP-HP specialized in the liver surgery and transplantation at Paul Brousse Hospital, Villejuif, France
              Speaker
              Riccardo Lencioni
              Director of the Division of Diagnostic Imaging and Intervention in the Department of Hepatology and Liver Transplantation at Pisa University Hospital in Italy
              • On-Demand Session
              Symposium: Cancer care beyond anti-tumor therapy
                Speaker(s)
                Speaker
                Florian Strasser
                Head of Integrated Oncological Rehabilitation at Klinik Gais AG, Switzerland, and Senior Consultant Clinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
                Speaker
                Maria Die Trill
                Coordinator of the Psycho-Oncology Unit of the Hospital Universitario Gregorio Marañón and Assistant Professor at the School of Psychology, Universidad Complutense of Madrid, Spain
                • On-Demand Session

                Friday, September 11, 2:00 PM - 3:00 PM

                ROCHE Industry Partner Symposium
                  How could treatment practice change with cancer immunotherapy combinations in patients with HCC? Welcome and introductions by Peter Galle Navigating the shifting treatment patterns for HCC by Jian Zhou Understanding the latest efficacy data for unresectable HCC by Peter Galle Discussing safety with cancer immunotherapy combinations by Bruno Sangro Making the correct clinical decisions: what do... Read More
                  • Industry Symposium

                  Friday, September 11, 3:00 PM - 4:00 PM

                  Young Investigator Session
                    The Young Investigator Session is hosted for researchers who are 35 years old or less. The session consists of 4 oral presentations from research submitted for the conference by young researchers followed by 20 minutes of Q&A from the participants. The official hour of the ILCA 2020 Virtual Conference is CEST... Read More
                    Speaker(s)
                    Oral Presenter
                    Catherine Willoughby
                    O-04: Cabozantinib Enhances The Efficacy And Immune Activity Of Anti-Pd1 Therapy In A Murine Model Of Hepatocellular Carcinoma
                    Oral Presenter
                    Helena Degroote
                    O-01: International, multicenter study on the outcome of locoregional therapy before liver transplant for hepatocellular carcinoma extending the Milan criteria
                    Oral Presenter
                    Hyo-Jin Kang
                    O-03: Prospective Intra-Individual Comparison Of Contrast-Enhanced Ultrasound With Sulfur Hexafluoride And Perfluorobutane For Diagnosis Of Hepatocellular
                    Moderator
                    Morris Sherman
                    Professor of Medicine at University of Toronto. ILCA Past President
                    Oral Presenter
                    Saur Hajiev
                    O-02: Impact Of Age On Sorafenib Outcomes In Hepatocellular Carcinoma: An International Cohort Study.
                    • General Session

                    Friday, September 11, 4:05 PM - 4:35 PM

                    Best Clinical Poster Question & Answer Session
                      10 Top scored clinical e-Posters presenters  will participate on this LIVE Question & Answer session where participants and specialists will ask poster presenters about findings described in their poster. The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local :  https://www.timeanddate.com/worldclock/converter-classic.html ...
                      Speaker(s)
                      Poster Presenter
                      Amit G.. Singal
                      P-47: Benefits And Harms Of Hepatocellular Carcinoma Surveillance In A Prospective Cohort Of Patients With Cirrhosis
                      Poster Presenter
                      Anand Mehta
                      P-40: A Fucosylated Kininogen-Based Biomarker Panel Is Highly Accurate For Early Detection Hepatocellular Carcinoma In Patients With Cirrhosis: A Phase Iii Biomarker Evaluation
                      Poster Presenter
                      Bruno Sangro
                      P-103: Exposure-Response Analysis For Nivolumab + Ipilimumab Combination Therapy In Patients With Advanced Hepatocellular Carcinoma
                      Moderator
                      Laura Kulik
                      Hepatology & Liver Transplantation Professor, Medicine, Northwestern University Medical School, Chicago
                      Poster Presenter
                      Lijuan Liu
                      P-32: Standardized Sampling And Reporting Protocol Is The Key To Improve Microvascular Invasion Detection Rate
                      Poster Presenter
                      Nathalie Ganne-Carrié
                      P-66: Overall Survival Is Impacted By Liver Failure And Co-Morbidities Rather Than Etiology Of Cirrhosis In Patients With Hepatocellular Carcinoma Detected During A Surveillance Program
                      Poster Presenter
                      Petros Fessas
                      P-109: Post-Registration Experience Of Nivolumab Therapy In Patients With Advanced Hepatocellular Carcinoma (Hcc): An International Study.
                      Poster Presenter
                      Philippe Merle
                      P-115: Sequential Treatment With Sorafenib Followed By Regorafenib In Patients With Unresectable Hepatocellular Carcinoma (HCC): Interim Analysis Of The Observational REFINE Study
                      Poster Presenter
                      Richard Finn
                      P-03: Ramucirumab For Patients With Advanced Hepatocellular Carcinoma And Elevated Alpha Fetoprotein Following A Non-Sorafenib Based Systemic Therapy: Interim Results From An Expansion Cohort Of The Phase 3 Reach-2 Study
                      Poster Presenter
                      Won Sohn
                      P-56: Abnormal And Euthyroid Ranges Of Thyroid Hormones In Serum And Liver Cancer Mortality: A Cohort Study
                      • Question & Answer

                      Friday, September 11, 4:40 PM - 5:40 PM

                      IPSEN Industry Partner Symposium
                        Faculty: Sandrine Faivre, Josep Llovet & Arndt Vogel (chair) Duration Topic Presenter 5 min Welcome and introductions Arndt Vogel 15 min Translating latest clinical trials evidence into treatment decisions Sandrine Faivre 15 min Sequencing of systemic therapy in today’s clinical practice Arndt Vogel 15 min Insights from the tumour microenvironment for the 2021 treatment landscape Josep Llovet 10 min Panel discussion and close All   This is... Read More
                        • Industry Symposium

                        Friday, September 11, 5:45 PM - 6:15 PM

                        Best Basic / Translational Poster Question & Answer Session
                          10 Top scored basic /translational e-Posters presenters  will participate on this LIVE Question & Answer session where participants and specialists will ask poster presenters about findings described in their poster. The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                          Speaker(s)
                          Moderator
                          Amaia Lujambio
                          Ph.D. Assistant Professor
                          Icahn School of Medicine at Mount Sinai
                          Poster Presenter
                          Amanda Craig
                          P-92: Characterization Of Chromatin Accessibility In Hepatocellular Carcinoma Cells Using Single Cell Atac Sequencing
                          Poster Presenter
                          David Repáraz
                          P-81: Cold-Inducible Rna Binding Protein As A Vaccination Platform Against Hepatocellular Carcinoma
                          Poster Presenter
                          Emilien Loeuillard
                          P-91: Dual Targeting Of Tumor Associated Macrophages And Immunosuppressive Granulocytic Myeloid-Derived Suppressor Cells Augments Pd-1 Blockade In Cholangiocarcinoma
                          Poster Presenter
                          Enric Vercher Herraez
                          P-77: Identification Of Neoantigen-Reactive Tumor-Infiltrating T Cell In Hepatocellular Carcinoma.
                          Poster Presenter
                          Josep Corominas Argente del Castillo
                          P-86: Activated Peripheral Blood Lypmphocytes Of Hepatocellular Carcinoma Patients (Hcc) Are Associated With Increased Risk Of Early Dermatologic Adverse Effects During Sorafenib Treatment
                          Poster Presenter
                          Laura Torrens
                          P-76: Immune-Remodeling Effects Of Lenvatinib Plus Anti-Pd1 In A Murine Model Of Hepatocellular Carcinoma
                          Poster Presenter
                          Liangqing Dong
                          P-70: Immunogenomic Characterization Of Multifocal Liver Cancer
                          Poster Presenter
                          Sarah Fritzsche
                          P-90: Implications Of Notch3 Expression And Signaling For Cholangiocarcinogenesis
                          Poster Presenter
                          Vatche Agopian
                          P-28: Purification And Digital Scoring Of Extracellular Vesicles For Detection Of Early-Stage Hepatocellular Carcinoma
                          • Question & Answer

                          Friday, September 11, 6:20 PM - 7:20 PM

                          INCYTE Industry Partner Symposium
                            • Industry Symposium

                            Friday, September 11, 7:20 PM - 7:40 PM

                            ILCA Junior Investigator Awards Ceremony
                              ILCA will recognise extraordinary achievements in liver cancer research across disciplines and support the professional development of four junior investigators in training. The award will be given for novel and significant liver cancer research across the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or... Read More
                              Speaker(s)
                              Session Chair
                              Augusto Villanueva
                              Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
                              Session Chair
                              Bruno Sangro
                              Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)
                              Session Chair
                              Morris Sherman
                              Professor of Medicine at University of Toronto. ILCA Past President
                              Session Chair
                              Sandrine Faivre
                              Professor of Medical Oncology at the University Paris VII

                                Saturday, September 12, 1:40 PM - 2:00 PM

                                Highlights of the day
                                  A summary conversation capturing the first day programme of presentations, panel discussions and the interactive dialogue at the conference day.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                  Speaker(s)
                                  Speaker
                                  Augusto Villanueva
                                  Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
                                  Speaker
                                  Laura Kulik
                                  Hepatology & Liver Transplantation Professor, Medicine, Northwestern University Medical School, Chicago
                                  • Wrap-up Session

                                  Saturday, September 12, 2:00 PM - 3:00 PM

                                  EISAI Industry Partner Symposium
                                    The evolving HCC treatment landscape: what is the role of LENVIMA® monotherapy in first-line uHCC?...
                                    • Industry Symposium

                                    Saturday, September 12, 3:00 PM - 4:00 PM

                                    General Session 1: Molecular Pathogenesis, Cell Biology and Translational Research
                                      4 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                                      Speaker(s)
                                      Oral Presenter
                                      Amaia Lujambio Goizueta
                                      O-08: Cooperation Between Distinct Cancer Driver Genes Underlies Inter-Tumor Heterogeneity In Hepatocellular Carcinoma
                                      Oral Presenter
                                      Geoffrey Fucile
                                      O-06: Supervised Learning Based On Tumor Imaging And Biopsy-Derived Transcriptomic Data Predicts Response Of Hepatocellular Carcinoma To Transarterial
                                      Moderator
                                      Jean Charles Nault
                                      Associated professor in Liver unit, Jean Verdier Hospital, Bondy, France. ILCA Communications Committee Chair.
                                      Oral Presenter
                                      Massih Ningarhari
                                      O-07: Telomere Length Is A Major Determinant Of Hepatocellular Carcinoma Diversity And A Therapeutic Target
                                      Oral Presenter
                                      Monika Lewinska
                                      O-05: Lysyl Oxidase Shapes Physical And Metabolic Interactions Between Tumor And Stroma In Cholangiocarcinoma Patients
                                      • General Session

                                      Saturday, September 12, 4:05 PM - 4:20 PM

                                      Q&A Basic Science Symposium : Molecular pathogenesis and targets in cholangiocarcinoma
                                        15 minutes Question & Answer sessions with 3 speakers and moderators. Participants will be able to ask questions through the Q&A box.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                        Speaker(s)
                                        Moderator
                                        Augusto Villanueva
                                        Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
                                        Speaker
                                        Daniela Sia
                                        Assistant Professor in the Division of Liver Diseases, Department of Medicine, at Icahn School of Medicine at Mount Sinai (ISMMS)
                                        Speaker
                                        Gregory Gores
                                        Executive Dean for Research, Physician Scientist
                                        Mayo Clinic
                                        Speaker
                                        Jesper B. Andersen
                                        Associate Professor and Group leader
                                        University of Copenhagen · Biotech Research and Innovation Centre (BRIC)
                                        • Symposium

                                        Saturday, September 12, 4:20 PM - 4:35 PM

                                        Q&A Sequencing and Stratification of Systemic Therapy in HCC Symposium
                                          15 minutes question & answers with the speakers and moderator. Participants will be able to ask questions in writing using the Q&A box. Questions & Answers will be asked  from the on-demand  symposium programme below: Sequencing and Stratification of Systemic Therapy in HCC Symposium Session Chairs: Lorenza Rimassa (Italy), R. Kate Kelley (USA) The Growing... Read More
                                          Speaker(s)
                                          Speaker
                                          David J. Pinato
                                          Clinical Senior Lecturer in Medical Oncology
                                          Imperial College London
                                          Speaker
                                          Josep Llovet
                                          Prof.
                                          IDIBAPS-HOSPITAL CLÍNIC / ICAHN SCHOOL OF MEDICINE
                                          Session Chair
                                          Lorenza Rimassa
                                          Deputy Director Medical Oncology Unit Humanitas Cancer Center Humanitas Research Hospital - IRCCS, Milan, Italy
                                          Speaker
                                          Maria Reig
                                          Hepatic Oncology (BCLC)
                                          Hospital Clinic - Barcelona
                                          Session Chair
                                          R.Kate Kelley
                                          Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).
                                          Speaker
                                          Richard Finn
                                          Professor of Clinical Medicine Division of Hematology/ Oncology UCLA David Geffen School of Medicine University of California, Los Angeles
                                          Speaker
                                          Stephen Chan
                                          Associate Professor
                                          Department of Clinical Oncology, The Chinese University of Hong Kong
                                          • Symposium

                                          Saturday, September 12, 4:40 PM - 4:55 PM

                                          Single Topic Workshop Q&A on "Molecular Diversity and Systemic Treatment for HCC" and "Surgery in the Management of HCC: Role of Surgeons and the Radiologists"
                                            15 minutes Question & Answer session with the speakers of the Single Topic Workshops and moderator. Participants will be able to ask questions in writing using the Q&A box.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to... Read More
                                            Speaker(s)
                                            Speaker
                                            Amaia Lujambio
                                            Ph.D. Assistant Professor
                                            Icahn School of Medicine at Mount Sinai
                                            Speaker
                                            Andrew Zhu
                                            Director of Jiahui International Cancer Center, Director Emeritus of Liver Cancer Research at Massachusetts General Hospital Cancer Center, and Professor of Medicine at Harvard Medical School
                                            Speaker
                                            Eric Vibert
                                            Academic surgeon at AP-HP specialized in the liver surgery and transplantation at Paul Brousse Hospital, Villejuif, France
                                            Moderator
                                            Jean Charles Nault
                                            Associated professor in Liver unit, Jean Verdier Hospital, Bondy, France. ILCA Communications Committee Chair.
                                            Speaker
                                            Riccardo Lencioni
                                            Director of the Division of Diagnostic Imaging and Intervention in the Department of Hepatology and Liver Transplantation at Pisa University Hospital in Italy
                                            • Workshops

                                            Saturday, September 12, 4:55 PM - 5:10 PM

                                            Q&A Symposium: Cancer care beyond anti-tumor therapy
                                              15 minutes Question & Answer sessions with 2 speakers and moderator. Participants will be able to ask questions through the Q&A box.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                              Speaker(s)
                                              Moderator
                                              Bruno Sangro
                                              Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)
                                              Speaker
                                              Florian Strasser
                                              Head of Integrated Oncological Rehabilitation at Klinik Gais AG, Switzerland, and Senior Consultant Clinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
                                              Speaker
                                              Maria Die Trill
                                              Coordinator of the Psycho-Oncology Unit of the Hospital Universitario Gregorio Marañón and Assistant Professor at the School of Psychology, Universidad Complutense of Madrid, Spain
                                              • Symposium

                                              Saturday, September 12, 5:15 PM - 6:45 PM

                                              General Session 2: Epidemiology, Staging and Prognosis
                                                6 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                                                Speaker(s)
                                                Oral Presenter
                                                Amit G. Singal
                                                O-13: Patient-Reported Barriers Are Associated With Hcc Surveillance Receipt In A Multi-Center Cohort Of Patients With Cirrhosis
                                                Oral Presenter
                                                Federico Piñero
                                                O-12: The Metroticket 2.0 And Afp Score Have Similar Performance To Predict Post-Lt Outcomes: Results Of A Multinational Multicentre Cohort Study.
                                                Oral Presenter
                                                Giulia Rovesti
                                                O-09: Prognostic Role Of Pecs2 Index In Advanced Biliary Tract Cancer Patients Treated With First Line Chemotherapy: Training And Validation Cohorts.
                                                Oral Presenter
                                                Giuliana Amaddeo
                                                O-15: A Multicenter, Cross-Section Study Of The Impact Of Covid-19 Pandemic On The Management Of Hepatocellular Carcinoma A High-Prevalence French Area.
                                                Oral Presenter
                                                Matthew Holzner
                                                O-14: Is Repeat Resection For Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes Of An International Multicenter Analysis
                                                Oral Presenter
                                                Dr.  Parissa Tabrizian
                                                O-10: Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-Institutional Study Of > 3000 Patients
                                                Moderator
                                                Sasan Roayaie
                                                MD, FACS. General Surgery (board-certified)
                                                • General Session

                                                Sunday, September 13, 1:40 PM - 2:00 PM

                                                Highlights of the day
                                                  A summary conversation capturing the second day programme of presentations, panel discussions and the interactive dialogue at the conference day.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                                  Speaker(s)
                                                  Speaker
                                                  Amaia Lujambio
                                                  Ph.D. Assistant Professor
                                                  Icahn School of Medicine at Mount Sinai
                                                  Speaker
                                                  Augusto Villanueva
                                                  Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.

                                                    Sunday, September 13, 2:00 PM - 3:00 PM

                                                    BOSTON SCIENTIFIC Industry Partner Symposium
                                                      Y90: A Step Towards Curative Therapies for HCC Long Term Outcomes of Liver Transplant Following Y90       Dr Talia Baker, Transplant Surgeon, University of Chicago, USA SIRT for Downstaging                                                                     Dr Peter Littler, Interventional Radiologist, Freeman Hospital, UK Positioning SIRT in the Treatment Algorithm                           Dr Julien Edeline, Medical Oncologist, Centre Eugene Marquis, France... Read More
                                                      • Industry Symposium

                                                      Sunday, September 13, 3:00 PM - 4:30 PM

                                                      General Session 3: Diagnosis, Imaging and Biomarkers
                                                        6 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                                                        Speaker(s)
                                                        Moderator
                                                        Amit Singal
                                                        Associate Professor at UT Southwestern Medical Center
                                                        Oral Presenter
                                                        Amit Singal
                                                        O-20: Improved Sensitivity For Early-Stage Hepatocellular Carcinoma Detection With A Novel Blood-Based Panel Of Methylated Dna And Protein Markers
                                                        Oral Presenter
                                                        Andrew X. Zhu
                                                        0-18: Alpha-Fetoprotein (AFP) Kinetics As A Potential Surrogate Biomarker In Patients (Pts) With Hepatocellular Carcinoma (HCC) Treated With Atezolizumab (Atezo) + Bevacizumab (Bev)
                                                        Oral Presenter
                                                        Han Xiao
                                                        O-16: Construction And Implementation Of An Artificial Intelligence Model For Microvascular Invasion Prediction Of Hepatocellular Carcinoma
                                                        Oral Presenter
                                                        Johann von Felden
                                                        O-19: Unannotated Small RNA In Circulating Extracellular Vesicles Detect Early Stage Liver Cancer
                                                        Oral Presenter
                                                        Takeshi Yokoo
                                                        O-17: Comparative Accuracy Of Abbreviated Mri Vs. Ultrasound For Detection Of Early-Stage Hcc In Patients With Cirrhosis
                                                        Oral Presenter
                                                        Xuehong Zhang
                                                        O-21: Inflammatory And Insulinemic Potential Of Diet And Lifestyle With Risk Of Hepatocellular Carcinoma
                                                        • General Session

                                                        Sunday, September 13, 4:35 PM - 4:50 PM

                                                        Q&A ILCA Systemic Therapy Guidance
                                                          The past few years have witnessed huge progress in the treatment of advanced HCC and the therapeutic landscape has been transformed. In order to provide comprehensive, up-to-date and readily accessible information about the latest treatment, ILCA have developed on-line guidance. The guidance will be launched at the ILCA 2020 conference... Read More
                                                          Speaker(s)
                                                          Speaker
                                                          R.Kate Kelley
                                                          Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).
                                                          Speaker
                                                          Tim Meyer
                                                          Professor of Experimental Cancer Medicine at UCL and Honorary Consultant in Medical Oncology at the Royal Free and ULCH Hospitals. ILCA Communication Committee Chair.
                                                          • Symposium

                                                          Sunday, September 13, 4:50 PM - 5:05 PM

                                                          Q&A ILCA Biomarker Development in HCC Guidance
                                                            15 minutes Q&A with speakers. Participants will be able to ask questions in writing using a Q&A box. The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                                            Speaker(s)
                                                            Speaker
                                                            Amit Singal
                                                            Associate Professor at UT Southwestern Medical Center
                                                            Speaker
                                                            Augusto Villanueva
                                                            Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
                                                            • Symposium

                                                            Sunday, September 13, 5:10 PM - 6:40 PM

                                                            General Session 4: Therapy and Clinical Trials
                                                              6 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                                                              Speaker(s)
                                                              Oral Presenter
                                                              Anthony B. El-Khoueiry
                                                              0-24: Outcomes For Patients With Advanced Hepatocellular Carcinoma And Child-Pugh B Liver Function In The Phase 3 Celestial Study Of Cabozantinib Versus Placebo
                                                              Oral Presenter
                                                              Bruno Sangro.
                                                              O:27: Nivolumab After Selective Internal Radiation Therapy (Sirt) Using Sir-Spheres Resin Microspheres In Patients With Hepatocellular Carcinoma: The Nasir-Hcc Trial
                                                              Oral Presenter
                                                              Joong-Won Park
                                                              O-26: Proton Beam Radiotherapy Versus Radiofrequency Ablation Treatment In Patients With Recurrent Hepatocellular Carcinoma: A Randomized Controlled Phase 3 Non-Inferiority Aproh Trial
                                                              Oral Presenter
                                                              Neil Mehta
                                                              O-23: Transarterial Chemoembolization And Radioembolization Are Similarly Effective In Achieving Successful Hepatocellular Carcinoma Downstaging In The Multicenter Evaluation Of Reduction In Tumor Size Before Liver Transplantation (Merits-Lt) Consortium
                                                              Oral Presenter
                                                              Pierre Nahon
                                                              0-25: Radiological And Pathological Response To Neoadjuvant Nivolumab In Patients With Bclc A Hcc Treated By Curative Percutaneous Irreversible Electroporation: Preliminary Report From The French Multicentre Phase 2 Nivolep Trial.
                                                              Oral Presenter
                                                              R. Katie Kelley
                                                              O-22: The Novel Regimen Of Tremelimumab In Combination With Durvalumab Provides A Favorable Safety Profile And Clinical Activity For Patients With Advanced
                                                              Moderator
                                                              Tim Meyer
                                                              Professor of Experimental Cancer Medicine at UCL and Honorary Consultant in Medical Oncology at the Royal Free and ULCH Hospitals. ILCA Communication Committee Chair.
                                                              • General Session

                                                              Sunday, September 13, 6:40 PM - 6:50 PM

                                                              Farewell Address
                                                                The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                                                Speaker(s)
                                                                Speaker
                                                                Bruno Sangro
                                                                Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)
                                                                • Closing Session